If people had concerns that unreasonable payments to physicians were driving up gabapentinoid use, after looking at these facts they should be less concerned that this is the case.
If people had concerns that unreasonable payments to physicians were driving up gabapentinoid use, after looking at these facts they should be less concerned that this is the case.